nitroaspirin has been researched along with phosphoserine in 1 studies
*Phosphoserine: The phosphoric acid ester of serine. [MeSH]
*Phosphoserine: The phosphoric acid ester of serine. [MeSH]
| Studies (nitroaspirin) | Trials (nitroaspirin) | Recent Studies (post-2010) (nitroaspirin) | Studies (phosphoserine) | Trials (phosphoserine) | Recent Studies (post-2010) (phosphoserine) |
|---|---|---|---|---|---|
| 127 | 9 | 8 | 3,337 | 3 | 830 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darzynkiewicz, Z; Halicka, HD; Huang, X; Kurose, A; Tanaka, T; Traganos, F | 1 |
1 other study(ies) available for nitroaspirin and phosphoserine
| Article | Year |
|---|---|
Nitrogen oxide-releasing aspirin induces histone H2AX phosphorylation, ATM activation and apoptosis preferentially in S-phase cells: involvement of reactive oxygen species.
Topics: Apoptosis; Aspirin; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Nucleus; Comet Assay; Cyclooxygenase Inhibitors; DNA-Binding Proteins; Histones; Humans; Phosphorylation; Phosphoserine; Protein Serine-Threonine Kinases; Reactive Oxygen Species; S Phase; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2006 |